RecruitingNCT03748069
Influenza Associated Aspergillosis In-depth Investigation
Unraveling the Pathogenesis of Influenza-associated Aspergillosis: a Single-center, Prospective Cohort Pilot Study
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
45 participants
Start Date
Jan 18, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- All patients older than 18 years, admitted to ICU with respiratory distress with microbiologically confirmed diagnosis of influenza (for inclusion in the influenza group)
- All patients older than 18 years, admitted to ICU for respiratory distress due to community- acquired pneumonia , with a microbiologically confirmed absence of influenza (for inclusion in the control group)
Exclusion Criteria3
- Age \< 18 years old
- Pregnant women
- No informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03748069
Related Trials
PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
NCT073135271 location
Breath Analysis for the Detection of Invasive Fungal Infections
NCT065377261 location
Early Diagnosis of Invasive Lung Aspergillosis
NCT058603877 locations